IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: I. Luttichuys who wrote (889)	5/18/1997 12:31:00 PM
From: AARON DIDICH	of 1762

OFF TOPIC Bennett: Just picked up the annual report of the RIGS scan developer and I will provide you with two names that either you may recognize or your friends on rotation may have contact with. John Daly, M.D. is a cancer researcher at Cornell U. Med Center at New York Hospital; he presented the Phase III data for RIGScan CR40 at the American College of Surgeons Meeting in Octobaer '96. A Michael Moore, M.D.,Ph.D. is listed as a member of the Board of Directors as an attending pysician, Breast Surgery, Columbia Presbyterian Medical Center. Of interest, I see that Melvin D. Booth is a member and he is currently President & COO of Human Genome Sciences. Stock went above 15 Friday and will be showcased later this week, e-mail me if you want details. Aaron P.S. Is Queen Vickie a pneumocephalic or what?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next